67.5 F
Santa Barbara
HomePublishingGlobal Tissue Sealants Clinical Pipeline Research Report 2023: Stages of Development, Segments,...

Global Tissue Sealants Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

DUBLIN, Jan. 16, 2024 /PRNewswire/ — The “Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” report has been added to  ResearchAndMarkets.com’s offering.

The Medical Devices sector report provides comprehensive information about the Tissue Sealants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue sealants serve primarily as a physical barrier to prevent leakage of fluid and/or gas from a surgical incision.


  • Extensive coverage of the Tissue Sealants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Sealants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Tissue Sealants Overview

3 Products under Development
3.1 Tissue Sealants – Pipeline Products by Stage of Development
3.2 Tissue Sealants – Pipeline Products by Segment
3.3 Tissue Sealants – Pipeline Products by Territory
3.4 Tissue Sealants – Pipeline Products by Regulatory Path
3.5 Tissue Sealants – Pipeline Products by Estimated Approval Date
3.6 Tissue Sealants – Ongoing Clinical Trials

4 Tissue Sealants – Pipeline Products under Development by Companies
4.1 Tissue Sealants Companies – Pipeline Products by Stage of Development
4.2 Tissue Sealants – Pipeline Products by Stage of Development

5 Tissue Sealants Companies and Product Overview

6 Tissue Sealants- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

  • Advanced Medical Solutions Group plc
  • Aleo BME Inc
  • Angiotech Pharmaceuticals Inc
  • Arch Therapeutics Inc
  • Arizona State University
  • Baxter International Inc
  • Biomedica Management Corp
  • Boston University
  • Calmare Therapeutics Inc
  • Clemson University
  • Cohera Medical Inc
  • Covalent Medical, Inc. (Inactive)
  • CR Bard Inc
  • Department of Biomedical Engineering Columbia University
  • DSM Biomedical BV
  • Eidgenossische Materialprufungs- und Forschungsanstalt
  • Elastagen Pty Ltd
  • Ethicon Endo-Surgery Inc
  • Gamma Diagnostics Inc
  • GATT Technologies BV
  • Hemostasis LLC
  • HyperBranch Medical Technology Inc
  • Innotherapy Inc
  • Institute of Molecular Biology of Parana
  • InVivo Therapeutics Corp
  • Johns Hopkins University
  • Kollodis BioSciences Inc
  • Kuros Biosciences AG
  • Laser Tissue Welding, Inc.
  • Medisse BV (Inactive)
  • Meril Life Sciences Pvt Ltd
  • Nurami Medical Ltd
  • Pharming Group NV
  • Polyganics BV
  • Protein Polymer Technologies Inc (Inactive)
  • Purdue University
  • Samyang Biopharmaceuticals Corp
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Sealonix Inc
  • Selio Medical
  • Shanghai Haohai Biological Technology Co Ltd
  • Surgical Sealants, Inc.
  • Teijin Pharma Ltd
  • Terasaki Institute for Biomedical Innovation
  • Tetratherix Pty Ltd
  • Texas A&M Engineering Experiment Station
  • Texas A&M University
  • The Medicines Co
  • Tissium SA
  • University of Akron

For more information about this report visit https://www.researchandmarkets.com/r/cz6of8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Originally published at https://www.prnewswire.com/news-releases/global-tissue-sealants-clinical-pipeline-research-report-2023-stages-of-development-segments-region-and-countries-regulatory-path-and-competitive-landscape-302035564.html
Images courtesy of https://pixabay.com

- Part of VUGA -digital marketing

latest articles

gossip news

explore more

fashion tv watch free